A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun YANG; Hyun-Young WOO; Soon-Kyu LEE; Ji-Won HAN; Bohyun JANG; Hee-Chul NAM; Hae-Lim LEE; Sung-Won LEE; Do-Seon SONG; Myeong-Jun SONG; Jung-Suk OH; Ho-Jong CHUN; Jeong-Won JANG; Angelo LOZADA; Si-Hyun BAE; Jong-Young CHOI; Seung-Kew YOON.
Clinical and Molecular Hepatology ; : 128-137, 2017.
Artículo en Inglés | WPRIM | ID: wpr-43206

Documentos relacionados

  1. The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
  2. Metronomic therapy in pediatric oncology: A snapshot.
  3. Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?
  4. Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE.
  5. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
  6. Photodynamic therapy for solid tumors: A review of the literature.
  7. Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens.
  8. SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumor.
  9. Comparative efficacy and safety of metronomic chemotherapy in breast cancer: A protocol for network meta-analysis protocol.
  10. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-center Study.